Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
1. April 2025
2 min to read

First Objective Definition of Hyperacute T-waves as a ST-segment Elevation Myocardial Infarction Equivalent ECG Finding

Overview

This abstract introduces the first objective definition of hyperacute T-waves (HATW) — an early and often missed ECG sign of a severe heart attack. By accurately detecting blocked arteries even before classic signs appear, the new formula helps doctors identify high-risk patients sooner and deliver life-saving treatment faster.

Published In: Journal of the American College of Cardiology (JACC) – presented at the annual ACC’25 conference
Published Date: April 1, 2025

Background

The American College of Cardiology recommends identifying hyperacute T waves (HATW) as a STEMI equivalent indicating the need for immediate invasive reperfusion strategy. Although HATW have been qualitatively described, they have no objective or quantifiable definition.

Methods

We developed a HATW rule to detect acute coronary occlusion in the absence of STEMI criteria by exploring a database of 12-lead ECGs of acute coronary syndrome patients with known angiographic outcomes. The rule applies to narrow QRS complex rhythms and requires 2 contiguous leads with both: 1) increased ratio of T-wave area to QRS amplitude (using lead-specific ratio thresholds), and 2) increased T-wave symmetry defined as T-wave peak at ≤ 67% of the J-T interval.

Results

1,333 ECGs from 605 patients (130 ECGs meeting formal STEMI criteria) were evaluated. The HATW formula demonstrated 37% sensitivity 98% specificity for acute coronary occlusion myocardial infarction among all patients, and 23% sensitivity and 98% specificity in patients without formal STEMI criteria.

Conclusion

This is the first quantitative analysis of HATW demonstrating its potential as a highly specific STEMI equivalent ECG finding of acute coronary occlusion. Further prospective validation of its performance is warranted.


Authors: Harvey Meyers, Frantisek Simancik, Anthony Demolder, Robert Herman, Timea Kisova, Adam Rafajdus, Jozef Bartunek, Emanuele Barbato, Stephen W. Smith

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Can an AI ECG algorithm improve diagnostic accuracy for acute coronary occlusion in the difficult subset of canceled catheterization lab activations?

Discordance in ECG interpretation between Emergency Medicine and Cardiology teams is common, and within canceled STEMI activations, a true acute coronary occlusion myocardial infarction (OMI) can go unrecognized. This retrospective study examined whether an AI ECG algorithm (Queen of Hearts™) could improve OMI detection in this difficult subset. Across three referral centers, the investigators analyzed 185 activations canceled for not meeting STEMI criteria, of which 17 met the definition of a missed OMI. The AI algorithm identified 16 of 17 cases, far exceeding STEMI criteria in sensitivity (94.1% vs. 47.1%), supporting its use as an adjunct to clinical judgment in ambiguous cases.

Artificial Intelligence-Assisted, ECG-Based Triage of Patients With Chest Pain to Immediate Invasive Treatment

Rapid identification of acute coronary occlusion (ACO) is critical in chest pain patients, yet conventional STEMI criteria miss occlusion in many NSTEMI cases, delaying life-saving invasive treatment. This retrospective study tested whether a deep learning ECG AI model could improve ACO detection in an unselected cohort of more than 4,000 consecutive patients from a German chest pain unit. Each 12-lead ECG was assessed using both standard STEMI criteria and the AI model, with ACO independently adjudicated by a blinded physician. The AI model clearly outperformed STEMI criteria, identifying 73 of 104 ACO cases versus 30 (area under the curve 0.958 vs. 0.589), with fewer false positives. The findings suggest AI-assisted ECG interpretation can detect subtle ischemic changes beyond established criteria and support faster triage of NSTE-ACO patients to immediate invasive care.

Join over 100,000 healthcare professionals who are already taking advantage of AI